Global Anesthesia Video Laryngoscope Market 2020 to 2025: Industry Trends, Share, Size, Growth, Opportunity and Forecast

December 11, 2020

The global anesthesia video laryngoscope market grew at a CAGR of around 6% during 2014-2019. Looking forward, the publisher expects the global anesthesia video laryngoscope market to exhibit moderate growth during the next five years.

An anesthesia video laryngoscope is an intubation device used to provide an around-the-corner view of the anterior larynx. It comprises blades, batteries, a camera and an attached monitor to display an enlarged image of the airway structure and facilitate endotracheal intubation (ETI). Unlike conventional direct laryngoscopy (DL), video laryngoscopy (VL) eliminates the requirement for a direct line of sight for practitioners and helps them carry out a detailed examination. Consequently, anesthesia video laryngoscopes are widely utilized in emergency or secondary care settings to manage complicated cases of laryngoscopy. They are also used as teaching tools in medical institutes, owing to their small size and portability.

Due to the rising cases of coronavirus disease (COVID-19), there is a rise in the demand for anesthesia video laryngoscopes to provide ETI to patients in the nonoperating room or off-site settings. It also keeps the faces of healthcare professionals away from the airways of patients, thereby minimizing the risk of transmission. These devices can also store the video stream on SD memory cards.

Apart from this, the rising prevalence of obesity, along with improvements in the healthcare infrastructure, has increased the adoption of anesthesia video laryngoscope. Besides this, the leading players are focusing on the introduction of product variants that aid in pediatric care. This, in confluence with the growing popularity of minimally invasive surgeries (MIS), is expected to impel the market growth in the coming years.

Companies Mentioned

  • Ambu A/S
  • ATMOS MedizinTechnik GmbH & Co. KG
  • BOMImed Inc.
  • Clarus Medical LLC
  • Daiken Medical Co Ltd.
  • KARL STORZ SE & Co. KG
  • Medtronic Plc
  • Olympus Corporation
  • Orlvision GmbH
  • Prosurg Inc.
  • Teleflex Incorporated
  • Velosal Medical Incorporated
  • Verathon Inc. (Roper Technologies)
  • XION GmbH

Key Questions Answered in This Report:

  • How has the global anesthesia video laryngoscope market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global anesthesia video laryngoscope market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the blade type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anesthesia video laryngoscope market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.3.1 Primary Sources

2.3.2 Secondary Sources

2.4 Market Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Anesthesia Video Laryngoscope Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Product

6.1 Rigid Laryngoscope

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Transnasal Flexible Laryngoscope

6.2.1 Market Trends

6.2.2 Market Forecast

7 Market Breakup by Blade Type

7.1 Channelled Blade Laryngoscope

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Non-Channelled Blade Laryngoscope

7.2.1 Market Trends

7.2.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Critical Care Centers

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Others

8.3.1 Market Trends

8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America

9.2 Asia Pacific

9.3 Europe

9.4 Latin America

9.5 Middle East and Africa

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”